Filter Results:
(200)
Show Results For
- All HBS Web (200)
- Faculty Publications (76)
Show Results For
- All HBS Web (200)
- Faculty Publications (76)
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's... View Details
Keywords: Julia Hanna
- 21 Nov 2006
- First Look
First Look: November 21, 2006
cost to identify and investigate. The Effect of File Sharing on Record Sales: An Empirical Analysis Authors:Felix Oberholzer-Gee and Koleman Strumpf Periodical:Journal of Political Economy (forthcoming) Abstract For industries ranging from software to View Details
Keywords: Sean Silverthorne
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
Ross to write the paper "Performance Pricing in Tough Times." Shapiro, an authority on marketing strategy and sales management, is the Malcolm P. McNair Professor of Marketing, Emeritus at Harvard Business School. Ross is a... View Details
- 02 Oct 2000
- Research & Ideas
The Dubious Logic of Global Megamergers
expansion." In this excerpt, they detail seven such strategies that corporate leaders can pursue. Pick Up the Scraps. As Peter Drucker recently noted, for every megamerger or large acquisition, there are usually several spin-offs, divestments, or asset View Details
Keywords: by Pankaj Ghemawat & Fariborz Ghadar
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
Nokia lowered its guidance for Q2 2012, explaining in a press release that "competitive industry dynamics are negatively affecting the Smart Devices business unit to a somewhat greater extent than previously expected.") "They decided that they were... View Details
Keywords: by Carmen Nobel
- 15 Jan 2013
- First Look
First Look: January 15
KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in View Details
Keywords: Sean Silverthorne
- 03 Feb 2015
- First Look
First Look: February 3
architecture, including business- and technology-related aspects. We apply our methodology to data gathered in a large pharmaceutical firm. We show that this methodology helps to identify layers in the firm's architecture associated with... View Details
Keywords: Sean Silverthorne
- 30 Aug 2016
- First Look
August 30, 2016
forthcoming Journal of Marketing Research Incentives versus Reciprocity: Insights from a Field Experiment By: Chung, Doug J., and Das Narayandas Abstract—We conduct a field experiment in which we vary the sales force compensation scheme... View Details
Keywords: Carmen Nobel
- 16 Oct 2007
- First Look
First Look: October 16, 2007
distribution of sales and profits across products. By enabling an analysis of the book acquisition, development, and marketing process from the perspective of the publisher, author, and agent, serves as a vehicle for contrasting different... View Details
Keywords: Sean Silverthorne
- 01 Aug 1998
- News
Spring Reunions: Milestones and Memories
which develops and markets pharmaceutical products. Starting at age 10, Bertarelli accompanied his father on business trips. By 17, he was helping to craft the company's annual budgets. He was 29 when he became CEO, just when Fabio... View Details
Keywords: Eileen K. McCluskey
- 28 Oct 2014
- First Look
First Look: October 28
Business School Case 515-007 Pfizer and AstraZeneca: Marketing an Acquisition (A) In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for View Details
Keywords: Carmen Nobel
- 07 Apr 2003
- Research & Ideas
XTV: Xerox’s Attempted Recovery From “Fumbling the Future”
with researchers at PARC. Much of that time was occupied with interviewing prospective customers who had significant problems with document management. For example, a pharmaceutical company that was applying for FDA approval had to manage... View Details
Keywords: by Henry Chesbrough
- 19 Dec 2005
- Research & Ideas
The Regional Slice of Your Global Strategy
the Japanese economy get off the ground, and the company's business there was dwarfed by its domestic business. But as Toyota's U.S. sales grew, political pressures increased the political and administrative distance between the two... View Details
Keywords: by Pankaj Ghemawat
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company Healthgen, leads View Details
Keywords: Sean Silverthorne
- 01 Jan 2003
- News
Greylock
as Fansteel Metallurgical Corp., Deseret Pharmaceutical Co., New England Nuclear Corp., and Velcro Industries. And by the summer of 1969, it was ready to hire its first associate, Henry McCance, fresh out of three years in defense systems... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
respond to this additional uncertainty by purchasing more products, thereby generating additional sales for the retailer. We refer to this phenomenon as the value of concealment and show that the retailer enjoys a positive and significant... View Details
Keywords: Dina Gerdeman
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars market entrants,... View Details
Keywords: Sean Silverthorne
- 23 Oct 2019
- News
After the Storm
class. When I started at Johnson & Johnson right after business school, I remember being the only African American female pharmaceutical sales rep in the mid-Atlantic region at that time. It’s a sad reality,... View Details
- 01 Jul 2008
- First Look
First Look: July 1, 2008
and inside sales force have been very successful in finding and bringing in new customers, in part because of a laser-like focus on increasing its marketing ROI. As ScriptLogic looks towards its next phase of growth, however, it is... View Details
Keywords: Martha Lagace
- 05 Aug 2008
- First Look
First Look: August 5, 2008
and by adjusting both fund purchases and full sales of stocks if their risky portfolios have performed well. Finally, the tendency for households to fully sell winning stocks is weaker for wealthy investors with diversified portfolios of... View Details
Keywords: Martha Lagace